Detalles de la búsqueda
1.
Immunogenicity and Vaccine Shedding After 1 or 2 Doses of rVSVΔG-ZEBOV-GP Ebola Vaccine (ERVEBO®): Results From a Phase 2, Randomized, Placebo-controlled Trial in Children and Adults.
Clin Infect Dis
; 78(4): 870-879, 2024 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37967326
2.
Ebola Virus Glycoprotein IgG Seroprevalence in Community Previously Affected by Ebola, Sierra Leone.
Emerg Infect Dis
; 28(3): 734-738, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35202536
3.
Polymorphism in a lincRNA Associates with a Doubled Risk of Pneumococcal Bacteremia in Kenyan Children.
Am J Hum Genet
; 98(6): 1092-1100, 2016 Jun 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27236921
4.
Observational study: 27 years of severe malaria surveillance in Kilifi, Kenya.
BMC Med
; 17(1): 124, 2019 07 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31280724
5.
Age, Spatial, and Temporal Variations in Hospital Admissions with Malaria in Kilifi County, Kenya: A 25-Year Longitudinal Observational Study.
PLoS Med
; 13(6): e1002047, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-27352303
6.
Bacteraemia in sickle cell anaemia is associated with low haemoglobin: a report of 890 admissions to a tertiary hospital in Tanzania.
Br J Haematol
; 171(2): 273-276, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26084722
7.
Lessons learnt from the first controlled human malaria infection study conducted in Nairobi, Kenya.
Malar J
; 14: 182, 2015 Apr 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-25927522
8.
Evaluation of Kilifi epilepsy education programme: a randomized controlled trial.
Epilepsia
; 55(2): 344-52, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24447063
9.
Prevalence of immunoglobulin G and M to SARS-CoV-2 and other human coronaviruses in The Democratic Republic of Congo, Sierra Leone, and Uganda: A longitudinal study.
Int J Infect Dis
; 131: 183-192, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37001799
10.
The Effect of Previous Exposure to Malaria Infection and Clinical Malaria Episodes on the Immune Response to the Two-Dose Ad26.ZEBOV, MVA-BN-Filo Ebola Vaccine Regimen.
Vaccines (Basel)
; 11(8)2023 Aug 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37631885
11.
Safety and immunogenicity of an Ad26.ZEBOV booster vaccine in Human Immunodeficiency Virus positive (HIV+) adults previously vaccinated with the Ad26.ZEBOV, MVA-BN-Filo vaccine regimen against Ebola: A single-arm, open-label Phase II clinical trial in Kenya and Uganda.
Vaccine
; 41(50): 7573-7580, 2023 Dec 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37981473
12.
Safety and immunogenicity of an Ad26.ZEBOV booster dose in children previously vaccinated with the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen: an open-label, non-randomised, phase 2 trial.
Lancet Infect Dis
; 23(3): 352-360, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36273490
13.
Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Leone.
Lancet Glob Health
; 11(11): e1743-e1752, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37858585
14.
Anti-merozoite antibodies induce natural killer cell effector function and are associated with immunity against malaria.
Sci Transl Med
; 15(682): eabn5993, 2023 02 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36753561
15.
Risk and causes of paediatric hospital-acquired bacteraemia in Kilifi District Hospital, Kenya: a prospective cohort study.
Lancet
; 378(9808): 2021-2027, 2011 Dec 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-22133536
16.
Relation between falciparum malaria and bacteraemia in Kenyan children: a population-based, case-control study and a longitudinal study.
Lancet
; 378(9799): 1316-23, 2011 Oct 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-21903251
17.
The microbiologic safety of umbilical cord blood transfusion for children with severe anemia in Mombasa, Kenya.
Transfusion
; 52(7): 1542-51, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22221267
18.
Prevalence of malaria and helminth infections in rural communities in northern Sierra Leone, a baseline study to inform Ebola vaccine study protocols.
PLoS One
; 17(7): e0270968, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35793331
19.
Immunogenicity and safety of one-dose human papillomavirus vaccine compared with two or three doses in Tanzanian girls (DoRIS): an open-label, randomised, non-inferiority trial.
Lancet Glob Health
; 10(10): e1473-e1484, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36113531
20.
Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial.
Lancet Infect Dis
; 22(1): 110-122, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34529962